AdaptHealth Corp. (AHCO) vs Jade Biosciences, Inc. (JBIO)

A side-by-side comparison of AdaptHealth Corp. and Jade Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AHCO vs JBIO

growth of $100 · dividends reinvested · last 5y
AHCO -79.8% (-27.4%/yr)JBIO -97.8% (-53.5%/yr)AHCO compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020222023202420252026$20$2
AHCO JBIO

AHCO vs JBIO: by the numbers

  • •JBIO is the larger company ($802M vs $782M market cap).
  • •Both run net losses; JBIO's is the smaller (0.00% vs -7.58% net margin).

Metrics side by side

Valuation

MetricAHCOJBIO
P/S ratio0.26N/A
P/B ratio0.571.82
EV / EBITDA6.62N/A
FCF yield12.50%N/A

Profitability

MetricAHCOJBIO
Gross margin10.37%0.00%
Operating margin-0.31%0.00%
Net margin-7.58%0.00%
ROE-16.56%-34.83%
ROIC-0.26%-37.39%

Growth (annualized)

MetricAHCOJBIO
Revenue CAGR (5Y)11.68%N/A
FCF CAGR (5Y)7.07%N/A
Total return CAGR (5Y)-24.65%-52.65%

Frequently asked

How have AHCO and JBIO total returns compared?
Over the past 5 years, AHCO delivered -24.65% and JBIO delivered -52.65% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.